Memidis Pharma proudly participated in the IGO-Doelencongres 2025, which took place from 26 to 28 March in De Doelen in Rotterdam. As a leading player in the field of women’s and men’s health, Memidis presented its latest innovations.
During the congress the emphasis was on sharing knowledge and promoting cooperation. At the Memidis stand they could obtain information about products such as Premeno, Hyalofemme, Deumavan, Swimcount Harvester.
The IGO Goals Congress, which celebrated its 25th edition this year, provided a platform for discussing the latest developments and challenges in healthcare.
With a strong focus on research and development, Memidis Pharma remains committed to improving healthcare, with the needs of both patients and healthcare providers at its core. The successful participation in the IGO-Doelencongres 2025 is proof of its continued commitment and involvement with gynaecologists.
